351 related articles for article (PubMed ID: 23821437)
21. Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections.
Böttcher-Friebertshäuser E; Lu Y; Meyer D; Sielaff F; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2012 Dec; 30(51):7374-80. PubMed ID: 23072892
[TBL] [Abstract][Full Text] [Related]
22. [Potentiation of infectivity and pathogenesis of influenza virus by host and bacterial proteases].
Nagatake T
Nihon Rinsho; 2003 Nov; 61(11):1892-6. PubMed ID: 14619427
[TBL] [Abstract][Full Text] [Related]
23. Cleavage of influenza A virus H1 hemagglutinin by swine respiratory bacterial proteases.
Callan RJ; Hartmann FA; West SE; Hinshaw VS
J Virol; 1997 Oct; 71(10):7579-85. PubMed ID: 9311838
[TBL] [Abstract][Full Text] [Related]
24. A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site.
Straus MR; Whittaker GR
PLoS One; 2017; 12(3):e0174827. PubMed ID: 28358853
[TBL] [Abstract][Full Text] [Related]
25. SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses.
Straus MR; Kinder JT; Segall M; Dutch RE; Whittaker GR
Virology; 2020 Apr; 543():43-53. PubMed ID: 32056846
[TBL] [Abstract][Full Text] [Related]
26. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation.
Galloway SE; Reed ML; Russell CJ; Steinhauer DA
PLoS Pathog; 2013 Feb; 9(2):e1003151. PubMed ID: 23459660
[TBL] [Abstract][Full Text] [Related]
27. Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium.
Beaulieu A; Gravel É; Cloutier A; Marois I; Colombo É; Désilets A; Verreault C; Leduc R; Marsault É; Richter MV
J Virol; 2013 Apr; 87(8):4237-51. PubMed ID: 23365447
[TBL] [Abstract][Full Text] [Related]
28. Exposure to ozone modulates human airway protease/antiprotease balance contributing to increased influenza A infection.
Kesic MJ; Meyer M; Bauer R; Jaspers I
PLoS One; 2012; 7(4):e35108. PubMed ID: 22496898
[TBL] [Abstract][Full Text] [Related]
29. Proteolytic activation of the 1918 influenza virus hemagglutinin.
Chaipan C; Kobasa D; Bertram S; Glowacka I; Steffen I; Tsegaye TS; Takeda M; Bugge TH; Kim S; Park Y; Marzi A; Pöhlmann S
J Virol; 2009 Apr; 83(7):3200-11. PubMed ID: 19158246
[TBL] [Abstract][Full Text] [Related]
30. Role of hemagglutinin cleavage for the pathogenicity of influenza virus.
Steinhauer DA
Virology; 1999 May; 258(1):1-20. PubMed ID: 10329563
[TBL] [Abstract][Full Text] [Related]
31. Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface.
Alvarado-Facundo E; Gao Y; Ribas-Aparicio RM; Jiménez-Alberto A; Weiss CD; Wang W
J Virol; 2015 Feb; 89(4):1975-85. PubMed ID: 25473053
[TBL] [Abstract][Full Text] [Related]
32. SPINK6 inhibits human airway serine proteases and restricts influenza virus activation.
Wang D; Li C; Chiu MC; Yu Y; Liu X; Zhao X; Huang J; Cheng Z; Yuan S; Poon V; Cai JP; Chu H; Chan JF; To KK; Yuen KY; Zhou J
EMBO Mol Med; 2022 Jan; 14(1):e14485. PubMed ID: 34826211
[TBL] [Abstract][Full Text] [Related]
33. Cleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12.
Hamilton BS; Whittaker GR
J Biol Chem; 2013 Jun; 288(24):17399-407. PubMed ID: 23612974
[TBL] [Abstract][Full Text] [Related]
34. Human matriptase/ST 14 proteolytically cleaves H7N9 hemagglutinin and facilitates the activation of influenza A/Shanghai/2/2013 virus in cell culture.
Whittaker GR; Straus MR
Influenza Other Respir Viruses; 2020 Mar; 14(2):189-195. PubMed ID: 31820577
[TBL] [Abstract][Full Text] [Related]
35. Airway proteases: an emerging drug target for influenza and other respiratory virus infections.
Laporte M; Naesens L
Curr Opin Virol; 2017 Jun; 24():16-24. PubMed ID: 28414992
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis between a low pathogenic and a high pathogenic influenza H5 hemagglutinin in cell entry.
Rumschlag-Booms E; Guo Y; Wang J; Caffrey M; Rong L
Virol J; 2009 Jun; 6():76. PubMed ID: 19515258
[TBL] [Abstract][Full Text] [Related]
37. Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases.
Zhirnov OP; Ikizler MR; Wright PF
J Virol; 2002 Sep; 76(17):8682-9. PubMed ID: 12163588
[TBL] [Abstract][Full Text] [Related]
38. Role of host trypsin-type serine proteases and influenza virus-cytokine-trypsin cycle in influenza viral pathogenesis. Pathogenesis-based therapeutic options.
Kido H; Takahashi E; Kimoto T
Biochimie; 2019 Nov; 166():203-213. PubMed ID: 31518617
[TBL] [Abstract][Full Text] [Related]
39. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
Kido H; Okumura Y; Yamada H; Le TQ; Yano M
Curr Pharm Des; 2007; 13(4):405-14. PubMed ID: 17311557
[TBL] [Abstract][Full Text] [Related]
40. HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3.
Hensen L; Matrosovich T; Roth K; Klenk HD; Matrosovich M
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
